Skip to main content

Definitive Healthcare Corp. (DH) Stock Forecast

Data as of Aug 7, 2026

Healthcare · Current price $0.68 (+2.61%)

Consensus Target
$2.45
Upside
+58.0%
Analysts
4
Rating
Hold(3.50)

Price Target Range

Low $1.10Consensus $2.45High $3.50
▲ Current $0.68

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Hold
Strong Buy0
Buy0
Hold0
Sell1
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

DH vs Sector & Market

MetricDHHealthcare AvgLarge Cap Avg
Analyst Rating3.502.252.42
Analyst Count4818
Target Upside+58.0%+16316.1%+17.2%
P/E Ratio-0.753.4135.26

Revenue Estimates

PeriodLowAvgHigh#
2026-09-30$55M$56M$57M4
2026-12-31$56M$57M$58M4
2027-03-31$54M$55M$56M4
2027-06-30$55M$56M$57M3
2027-09-30$55M$56M$57M3
2027-12-31$56M$57M$58M3
2028-12-31$241M$241M$241M1

EPS Estimates

PeriodLowAvgHigh#
2026-09-30$0.04$0.04$0.043
2026-12-31$0.05$0.05$0.056
2027-03-31$0.04$0.04$0.053
2027-06-30$0.05$0.05$0.055
2027-09-30$0.05$0.05$0.053
2027-12-31$0.05$0.05$0.056
2028-12-31$0.20$0.20$0.213

Frequently Asked Questions

What is the analyst consensus for DH?

The consensus among 4 analysts covering Definitive Healthcare Corp. (DH) is Hold with an average price target of $2.45.

What is the highest price target for DH?

The highest analyst price target for DH is $3.50.

What is the lowest price target for DH?

The lowest analyst price target for DH is $1.10.

How many analysts cover DH?

4 analysts have issued ratings for Definitive Healthcare Corp. in the past 12 months.

Is DH a buy or sell right now?

Based on 4 analyst ratings, DH has a consensus rating of Hold (3.50/5) with a +58.0% upside to the consensus target of $2.45.

What are the earnings estimates for DH?

Analysts estimate DH will report EPS of $0.04 for the period ending 2026-09-30, with revenue estimated at $56M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.